ACRS - Aclaris Therapeutics, Inc.
4.88
-0.070 -1.434%
Share volume: 948,792
Last Updated: 05-12-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$4.95
-0.07
-0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-07-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | 05-07-2026 | |
| Total revenue | 2.766 M | 4.346 M | 9.210 M | 1.455 M | 1.777 M | 3.299 M | 1.295 M | 1.996 M | |
| Cost of revenue | 624.000 K | 654.000 K | 705.000 K | 506.000 K | 515.000 K | 538.000 K | 532.000 K | 395.000 K | |
| Gross profit | 2.142 M | 3.692 M | 8.505 M | 949.000 K | 1.262 M | 2.761 M | 763.000 K | 1.601 M | |
| 72.36% | 130.36% | -88.84% | 32.98% | 118.78% | -72.37% | 109.83% | |||
| Operating expenses | 13.511 M | 11.609 M | 100.885 M | 17.723 M | 16.835 M | 17.899 M | 22.160 M | 22.400 M | |
| Selling general and admin | 4.752 M | 5.653 M | 4.954 M | 6.139 M | 5.386 M | 4.871 M | 5.576 M | 6.743 M | |
| Research and development | 8.759 M | 5.956 M | 95.931 M | 11.584 M | 11.449 M | 13.028 M | 16.584 M | 15.657 M | |
| Total expenses | 14.996 M | 14.163 M | 108.181 M | 19.033 M | 19.670 M | 19.910 M | 23.497 M | 23.793 M | |
| -5.55% | 663.83% | -82.41% | 3.35% | 1.22% | 18.02% | 1.26% | |||
| Operating income | -12.854 M | -10.471 M | -99.676 M | -18.084 M | -18.408 M | -17.149 M | -22.734 M | -22.192 M | |
| Ebit | -10.986 M | -10.471 M | -99.676 M | -18.084 M | -18.408 M | -17.149 M | -22.734 M | -22.192 M | |
| Pretax income | -10.986 M | -10.471 M | -91.677 M | -18.084 M | -18.408 M | -17.149 M | -22.734 M | -22.192 M | |
| -4.69% | 775.53% | -80.27% | 1.79% | -6.84% | 32.57% | -2.38% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.986 M | -7.586 M | -96.552 M | -15.085 M | -15.429 M | -14.614 M | -19.795 M | -19.824 M | |
| 30.95% | -1,172.77% | 84.38% | -2.28% | 5.28% | -35.45% | -0.15% |